Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IGV-001 |
Trade Name | |
Synonyms | IGV001|IGV 001 |
Drug Descriptions |
IGV-001 is a preparation of IGF type 1 receptor antisense oligo-treated autologous glioblastoma tumor cells, which may induce anti-tumor immune response in glioblastoma patients (PMID: 33500356). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C101257 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IGV-001 | IGV-001 | 0 | 0 |
IGV-001 + Temozolomide | IGV-001 Temozolomide | 0 | 1 |